Submitted:
14 April 2026
Posted:
15 April 2026
You are already at the latest version
Abstract
Keywords:
MSC: 92C60; 34A34, 34C23, 34C60, 92-08
1. Introduction
2. The Model
- A summary of the definitions of the model parameters is given in Table 1.
3. Positivity, Boundedness and Existence
- We summarize our results as follows.
4. Steady States
4.1. Disease Free Equilibrium
- It follows, that somewhat artificially, we may write the basic stability number asThen, when the DFE is stable and attracting, and when it is unstable. As can be seen below, when the DFE is unstable the EE appears and is stable and attracting.
4.2. Endemic Equilibrium
5. Simulations
5.1. Numerical Scheme
| Algorithm 1 Explicit time-stepping |
|
Set and using (31) for n = 0 to N-1 do Calculate, in this order, and according to (25)–(29) Calculate and according to (30) end for |
5.2. DFE and EE Simulations
6. Numerical Convergence
7. Conclusions
References
- Moore, Janice, and Shillor, Meir. “A Modified SIR Model with Dependent Infection and Hospitalization Rates.” BIOMATH, vol. 13, no. 2, Dec. 2024, p. 2411146. [CrossRef]
- Cesmelioglu, Aycil, et al. A Mathematical Model of the COVID-19 Pandemic Dynamics with Dependent Variable Infection Rate: Application to the Republic of Korea. ArXiv.org, 2020, arxiv.org/abs/2008.03248.
- Pell, Bruce, Aigerim Kalizhanova, Aisha Tursynkozha, Denise Dengi, Ardak Kashkynbayev, and Yang Kuang. “Dynamic PD-L1 regulation shapes tumor immune escape and response to immunotherapy.” Cancers 2025, Vol. 17, 3803. [CrossRef] [PubMed]
- Hethcote, HerbertW. The Mathematics of Infectious Diseases. SIAM Rev., vol. 42, no. 4, 2000, pp. 599–653. [CrossRef]
- Wikipedia. “Compartmental Models (Epidemiology).” Wikipedia, Wikimedia Foundation, 11 May 2025, en.wikipedia.org/wiki/Compartmental_model_(epidemiology).
- Atherstone, Christine J., et al. COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020-2021. Emerging Infectious Diseases, vol. 29, no. 9, Sept. 2023, pp. 1757–1764. [CrossRef] [PubMed]
- Coppock, Dagan, et al. “COVID-19 Treatment Combinations and Associations with Mortality in a Large Multi-Site Healthcare System.” PLOS ONE, edited by Juan Carlos Lopez-Delgado, vol. 16, no. 6, June 2021, e0252591. [CrossRef] [PubMed]
- Liu, Jing, et al. “Differences in Case-Fatality-Rate of Emerging SARS-CoV-2 Variants.” Public Health in Practice, vol. 5, Dec. 2022, p. 100350. [CrossRef] [PubMed]
- Kojima, Noah, and Klausner, Jeffrey D. “Protective Immunity after Recovery from SARS-CoV-2 Infection.” The Lancet Infectious Diseases, Vol. 22 no 1, Jan, 2022. [CrossRef] [PubMed]
- Jahedi, Sana, and Yorke. James A. “When the Best Pandemic Models Are the Simplest.” Biology, vol. 9, no. 11, Oct. 2020, p. 353. [CrossRef] [PubMed]
- Allen, Linda J. S. An Introduction to Mathematical Biology. Pearson; Prentice Hall, 2007.
- Kloeden, Peter, and Rasmussen, Martin. “Nonautonomous Dynamical Systems.” Mathematical Surveys, American Mathematical Society, 2011. [CrossRef]



| Parameter | Description |
| P | recruitment rate of susceptible individuals |
| (restricted) disease-induced death rate (10) | |
| (restricted) infectivity rate (10) | |
| natural death rate | |
| recovery rate of infected | |
| loss of immunity rate of recovered | |
| disease-induced death limits | |
| infectivity limits | |
| restriction intervals values for | |
| restriction intervals values for | |
| initial populations | |
| initial rates |
| Parameter | DFE | EE |
| P | 1.4 | 3.4 |
| - | - | - | ||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).